President Donald Trump signed an executive order on Wednesday calling for health officials to build a six-month stockpile of active pharmaceutical ingredients for “critical” drugs in the US.
The Office of the Assistant Secretary for Preparedness and Response (ASPR) within HHS has 30 days to compile a list of the approximately 26 drugs, according to the executive order.
The order comes as the biopharma industry awaits details surrounding industry-specific tariffs, following the Department of Commerce’s Section 232 investigation which started in April.
There are also growing concerns that drugmakers could turn to cheaper sources, like China, for raw materials to ease the impact of US tariffs. This week, AbbVie detailed its plan to build an API factory in the US.
Like almost all governmental ideas, it makes a lot of sense. Surely you would want a stockpile of (I dunno) sufficient amounts of amoxicillin, and better the government to stockpile it than private individuals or organizations. I'm a little amused and/or suspicious that the government is going to source them "from domestic manufacturers where possible" - good luck with that, folks. [insert cynical comment here]
No comments:
Post a Comment
looks like Blogger doesn't work with anonymous comments from Chrome browsers at the moment - works in Microsoft Edge, or from Chrome with a Blogger account - sorry! CJ 3/21/20